EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Sees Large Growth in Short Interest

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 192,041 shares, an increase of 4,525.3% from the May 31st total of 4,152 shares. Based on an average daily trading volume, of 331,947 shares, the short-interest ratio is currently 0.6 days. Currently, 0.0% of the company’s stock are short sold.

EssilorLuxottica Stock Performance

OTCMKTS ESLOY opened at $94.47 on Friday. EssilorLuxottica has a 52 week low of $93.42 and a 52 week high of $186.81. The firm has a 50 day moving average of $104.40 and a two-hundred day moving average of $128.91. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.

Wall Street Analyst Weigh In

Several brokerages have commented on ESLOY. Zacks Research cut shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft initiated coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They set a “hold” rating for the company. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.